Oncology (all articles)
Guideline for Pancreatic Cancer: A summary of evidence-based surgical approaches.
12 May, 2022 | 10:09h | UTC
M-A: Chemoradiotherapy followed by active surveillance vs. standard esophagectomy for esophageal cancer.
12 May, 2022 | 07:51h | UTCChemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysis – Annals of Surgery (link to abstract – $ for full-text)
M-A: Complication rates of total thyroidectomy vs. hemithyroidectomy for treatment of papillary thyroid microcarcinoma.
11 May, 2022 | 10:59h | UTCComplication Rates of Total Thyroidectomy vs Hemithyroidectomy for Treatment of Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – $ for full-text)
Commentary on Twitter
In this systematic review and #meta-analysis, complications in the surgical management of micropapillary #thyroid carcinoma increased with the extent of surgery performed, although complications and recurrence were low for both operations. https://t.co/Itf14o38Vu @wiscsurgery
— JAMA Otolaryngology – Head & Neck Surgery (@JAMAOto) May 6, 2022
Systematic Review: Prevalence of opioid use disorder among patients with cancer-related pain.
11 May, 2022 | 10:46h | UTC
Guideline: Endoscopic submucosal dissection for superficial gastrointestinal lesions.
10 May, 2022 | 10:53h | UTC
RCT: Final analysis of 3 vs. 6 months of adjuvant Oxaliplatin and Fluoropyrimidine-based therapy in patients with Stage III colon cancer.
10 May, 2022 | 10:40h | UTC
Commentaries on Twitter
https://twitter.com/drkpavithran/status/1522370036072996865
M-A: Comparison of survival among adults with rectal cancer who have undergone laparoscopic vs. open surgery.
10 May, 2022 | 10:43h | UTC
Commentary on Twitter
This meta-analysis of 12 RCTs found laparoscopic rectal cancer resection is associated with better long-term overall survival vs open surgery, suggesting it may be time for routine use of laparoscopic surgery for rectal cancer. https://t.co/jb7YAkHDWM
— JAMA Network Open (@JAMANetworkOpen) May 9, 2022
Maternal and neonatal outcomes in women with a history of chemotherapy exposure: a population-based study of 8 million obstetric admissions.
10 May, 2022 | 10:38h | UTCMaternal and neonatal outcomes in women with a history of chemotherapy exposure: a population-based study of 8 million obstetric admissions – Archives of Gynecology and Obstetrics (link to abstract – $ for full-text)
Commentary on Twitter
May 7: Women with a history of chemotherapy were more likely to suffer from obstetric and medical complications including pre-eclampsia, chorioamnionitis, postpartum hemorrhage, and venous thromboembolism as well as an increased risk in overall mortality. https://t.co/FqC5HT52N9
— All Source Pregnancy (@PregnancyAll) May 8, 2022
Current and future colorectal cancer screening strategies.
10 May, 2022 | 10:34h | UTCCurrent and future colorectal cancer screening strategies – Nature Reviews Gastroenterology & Hepatology (if the link is paywalled, try this one in PMC)
Review: Assessment and management of cognitive function in patients with prostate cancer treated with second-generation androgen receptor pathway inhibitors.
10 May, 2022 | 10:32h | UTC
Retrospective Cohort Study: Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer.
9 May, 2022 | 01:40h | UTC
Commentary on Twitter
BD-IPMN 🍇 at very low risk of cancer 🔎 how to identify patients for surveillance
🌐 Multicentre Pancreas 2000 study of @EurPancClub
⚠️ 20% develop WF/HRS at FU
🏁 80% with WF/HRS still surveilled safely👉 MOST BD IPMN will never need surgery 👈https://t.co/YPHaQd98u1 pic.twitter.com/ypglRlNR2q
— Giovanni Marchegiani (@Gio_Marchegiani) May 7, 2022
A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles.
6 May, 2022 | 10:52h | UTC
Review: Pharmacologic management of persistent pain in cancer survivors.
6 May, 2022 | 10:34h | UTCPharmacologic Management of Persistent Pain in Cancer Survivors – Drugs
First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment.
6 May, 2022 | 10:27h | UTC
Review: Outcomes of Enhanced Recovery after Surgery (ERAS) in gynecologic oncology.
6 May, 2022 | 10:22h | UTC
Review: Advances in radiation oncology for the treatment of cervical cancer.
6 May, 2022 | 10:20h | UTCAdvances in Radiation Oncology for the Treatment of Cervical Cancer – Current Oncology
Cohort Study: Recurrence and mortality risk of Merkel cell carcinoma by cancer stage and time from diagnosis.
5 May, 2022 | 10:14h | UTCRecurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis – JAMA Dermatology (link to abstract – $ for full-text)
Author Interview: Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis
News Release: Patients with rare skin cancer, Merkel cell carcinoma, face 40% recurrence rate – University of Washington School of Medicine
Commentary on Twitter
In this cohort study, Merkel cell carcinoma (MCC) recurrence rate was 40%, more than 90% of MCC recurrences arose within 3 years. https://t.co/46rDnVtyHh
— JAMA Dermatology (@JAMADerm) February 23, 2022
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer.
5 May, 2022 | 10:16h | UTC
Review: A global approach to improving penile cancer care.
5 May, 2022 | 09:55h | UTCA global approach to improving penile cancer care – Nature Reviews Urology (if the link is paywalled, try this one)
Update on image-guided thermal lung ablation: Society guidelines, therapeutic alternatives, and postablation imaging findings.
4 May, 2022 | 08:14h | UTC
Recommendations for breast cancer screening in women with extremely dense breasts.
4 May, 2022 | 08:11h | UTC
SEOM—GECOD clinical guideline for unknown primary cancer.
4 May, 2022 | 08:12h | UTC
RCT: Improved survival with enzalutamide in patients with metastatic hormone-sensitive prostate cancer.
3 May, 2022 | 10:38h | UTC
Commentary on Twitter
🆕 #JCO #ClinicalTrialUpdate: ARCHES trial – 📈 Enzalutamide + ADT improved OS in men with metastatic horomone-sensitive #ProstateCancer 👉 https://t.co/FQ1lViCTZz #PCSM @AarmstrongDuke pic.twitter.com/fLs6PdFYlr
— Journal of Clinical Oncology (@JCO_ASCO) April 27, 2022
M-A: Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment.
3 May, 2022 | 10:33h | UTC
RCT: Topical imiquimod versus surgery for vulvar intraepithelial neoplasia.
3 May, 2022 | 10:30h | UTCTopical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial – The Lancet (link to abstract – $ for full-text)